IGF1 and cancer: Additionally, an evaluation of meta-analyses of biomarker associations with cancer risk [197] concluded that there may be bias present specifically in the meta-analyses of IGF with cancer risk, of which the Rowlands meta-analysis was one; by removing studies with the highest risk of bias, it is possible some bias has been removed.